These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 12517042

  • 1. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study.
    Chu SY, Tsai WY, Chen LH, Wei ML, Chien YH, Hwu WL.
    J Formos Med Assoc; 2002 Oct; 101(10):691-4. PubMed ID: 12517042
    [Abstract] [Full Text] [Related]

  • 2. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan 17; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 6. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
    Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb 20; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 10. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN.
    J Pediatr (Rio J); 2014 Feb 20; 90(3):300-7. PubMed ID: 24560529
    [Abstract] [Full Text] [Related]

  • 11. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.
    J Paediatr Child Health; 2008 Oct 20; 44(10):554-9. PubMed ID: 19012627
    [Abstract] [Full Text] [Related]

  • 12. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
    Mikami A, Fukushi M, Oda H, Fujita K, Fujieda K.
    Southeast Asian J Trop Med Public Health; 1999 Oct 20; 30 Suppl 2():100-2. PubMed ID: 11400741
    [Abstract] [Full Text] [Related]

  • 13. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun 20; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 14. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.
    Pediatrics; 1998 Apr 20; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [Abstract] [Full Text] [Related]

  • 15. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
    Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302
    [Abstract] [Full Text] [Related]

  • 16. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M, Dauerer E, DiRienzo AG, Caggana M, Tavakoli NP.
    Eur J Pediatr; 2017 Jan 26; 176(1):121-129. PubMed ID: 27900477
    [Abstract] [Full Text] [Related]

  • 17. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct 26; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 18. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct 26; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC, Carvajal F, Frómeta A, Arteaga AL, Castells EM, Espinosa T, Coto R, Pérez PL, Tejeda Y, Del Río L, Segura MT, Almenares P, Robaina R, Fernández JL.
    Clin Chim Acta; 2013 Jun 05; 421():73-8. PubMed ID: 23481450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.